PROCESS AND PRODUCT AMENDMENT. 7.2.1 Catapult confirms that it approved the information contained in the initial POD provided as part of the On-boarding Project as describing the COLLABORATOR Manufacturing Process and COLLABORATOR Product that can and may be developed, implemented, and manufactured in the Module by COLLABORATOR. The initial COLLABORATOR Product provided as part of the On-boarding Project has been included in the QTA Product List, and, therefore, constitutes a COLLABORATOR Product. It further confirms that such approval of COLLABORATOR Product will remain valid during the Term on the condition that no amendments are made at a later stage.
PROCESS AND PRODUCT AMENDMENT. 7.2.1 The Parties acknowledge that the initial ADAPTIMMUNE Product(s) and ADAPTIMMUNE Manufacturing Process(es) were disclosed by ADAPTIMMUNE to Catapult in the Pre-Screen Questionnaire submitted to Catapult. Catapult confirms that it approved the information provided by ADAPTIMMUNE at the Pre-Screen Questionnaire stage and the definition of the ADAPTIMMUNE Product and Manufacturing Process described in the Product Overview Document (POD). It further confirms that such approval will remain valid during the Term on the condition that no amendments are made at a later stage.
PROCESS AND PRODUCT AMENDMENT. 7.2.1 Catapult confirms that it approved the COLLABORATOR Product included in the QTA Product List. It further confirms that such approval of COLLABORATOR Product will remain valid during the Term on the condition that no amendments are made at a later stage.
